The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cholera Vaccine (Oral Route) Market Research Report 2025
Synopsis
The global Cholera Vaccine (Oral Route) market was valued at US$ 1027.9 million in 2023 and is anticipated to reach US$ 1525.6 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cholera Vaccine (Oral Route), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholera Vaccine (Oral Route).
Report Scope
The Cholera Vaccine (Oral Route) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholera Vaccine (Oral Route) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholera Vaccine (Oral Route) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Segment by Type
Shanchol
Dukoral
Vaxchora
Others
Segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cholera Vaccine (Oral Route) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Cholera Vaccine (Oral Route) market was valued at US$ 1027.9 million in 2023 and is anticipated to reach US$ 1525.6 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cholera Vaccine (Oral Route), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholera Vaccine (Oral Route).
Report Scope
The Cholera Vaccine (Oral Route) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholera Vaccine (Oral Route) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholera Vaccine (Oral Route) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Segment by Type
Shanchol
Dukoral
Vaxchora
Others
Segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cholera Vaccine (Oral Route) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cholera Vaccine (Oral Route) Market Overview
1.1 Product Overview and Scope of Cholera Vaccine (Oral Route)
1.2 Cholera Vaccine (Oral Route) Segment by Type
1.2.1 Global Cholera Vaccine (Oral Route) Market Value Comparison by Type (2024-2030)
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Cholera Vaccine (Oral Route) Segment by Application
1.3.1 Global Cholera Vaccine (Oral Route) Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Cholera Vaccine (Oral Route) Market Size Estimates and Forecasts
1.4.1 Global Cholera Vaccine (Oral Route) Revenue 2019-2030
1.4.2 Global Cholera Vaccine (Oral Route) Sales 2019-2030
1.4.3 Global Cholera Vaccine (Oral Route) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cholera Vaccine (Oral Route) Market Competition by Manufacturers
2.1 Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cholera Vaccine (Oral Route) Average Price by Manufacturers (2019-2024)
2.4 Global Cholera Vaccine (Oral Route) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cholera Vaccine (Oral Route), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cholera Vaccine (Oral Route), Product Type & Application
2.7 Cholera Vaccine (Oral Route) Market Competitive Situation and Trends
2.7.1 Cholera Vaccine (Oral Route) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cholera Vaccine (Oral Route) Players Market Share by Revenue
2.7.3 Global Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cholera Vaccine (Oral Route) Retrospective Market Scenario by Region
3.1 Global Cholera Vaccine (Oral Route) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cholera Vaccine (Oral Route) Global Cholera Vaccine (Oral Route) Sales by Region: 2019-2030
3.2.1 Global Cholera Vaccine (Oral Route) Sales by Region: 2019-2024
3.2.2 Global Cholera Vaccine (Oral Route) Sales by Region: 2025-2030
3.3 Global Cholera Vaccine (Oral Route) Global Cholera Vaccine (Oral Route) Revenue by Region: 2019-2030
3.3.1 Global Cholera Vaccine (Oral Route) Revenue by Region: 2019-2024
3.3.2 Global Cholera Vaccine (Oral Route) Revenue by Region: 2025-2030
3.4 North America Cholera Vaccine (Oral Route) Market Facts & Figures by Country
3.4.1 North America Cholera Vaccine (Oral Route) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cholera Vaccine (Oral Route) Sales by Country (2019-2030)
3.4.3 North America Cholera Vaccine (Oral Route) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cholera Vaccine (Oral Route) Market Facts & Figures by Country
3.5.1 Europe Cholera Vaccine (Oral Route) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cholera Vaccine (Oral Route) Sales by Country (2019-2030)
3.5.3 Europe Cholera Vaccine (Oral Route) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cholera Vaccine (Oral Route) Market Facts & Figures by Country
3.6.1 Asia Pacific Cholera Vaccine (Oral Route) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cholera Vaccine (Oral Route) Sales by Country (2019-2030)
3.6.3 Asia Pacific Cholera Vaccine (Oral Route) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cholera Vaccine (Oral Route) Market Facts & Figures by Country
3.7.1 Latin America Cholera Vaccine (Oral Route) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cholera Vaccine (Oral Route) Sales by Country (2019-2030)
3.7.3 Latin America Cholera Vaccine (Oral Route) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cholera Vaccine (Oral Route) Market Facts & Figures by Country
3.8.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cholera Vaccine (Oral Route) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cholera Vaccine (Oral Route) Sales by Type (2019-2030)
4.1.1 Global Cholera Vaccine (Oral Route) Sales by Type (2019-2024)
4.1.2 Global Cholera Vaccine (Oral Route) Sales by Type (2025-2030)
4.1.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2019-2030)
4.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2019-2030)
4.2.1 Global Cholera Vaccine (Oral Route) Revenue by Type (2019-2024)
4.2.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2025-2030)
4.2.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2019-2030)
4.3 Global Cholera Vaccine (Oral Route) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cholera Vaccine (Oral Route) Sales by Application (2019-2030)
5.1.1 Global Cholera Vaccine (Oral Route) Sales by Application (2019-2024)
5.1.2 Global Cholera Vaccine (Oral Route) Sales by Application (2025-2030)
5.1.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2019-2030)
5.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2019-2030)
5.2.1 Global Cholera Vaccine (Oral Route) Revenue by Application (2019-2024)
5.2.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2025-2030)
5.2.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2019-2030)
5.3 Global Cholera Vaccine (Oral Route) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PaxVax
6.1.1 PaxVax Corporation Information
6.1.2 PaxVax Description and Business Overview
6.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PaxVax Cholera Vaccine (Oral Route) Product Portfolio
6.1.5 PaxVax Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Cholera Vaccine (Oral Route) Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Valneva
6.3.1 Valneva Corporation Information
6.3.2 Valneva Description and Business Overview
6.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Valneva Cholera Vaccine (Oral Route) Product Portfolio
6.3.5 Valneva Recent Developments/Updates
6.4 EuBiologics
6.4.1 EuBiologics Corporation Information
6.4.2 EuBiologics Description and Business Overview
6.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EuBiologics Cholera Vaccine (Oral Route) Product Portfolio
6.4.5 EuBiologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cholera Vaccine (Oral Route) Industry Chain Analysis
7.2 Cholera Vaccine (Oral Route) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cholera Vaccine (Oral Route) Production Mode & Process
7.4 Cholera Vaccine (Oral Route) Sales and Marketing
7.4.1 Cholera Vaccine (Oral Route) Sales Channels
7.4.2 Cholera Vaccine (Oral Route) Distributors
7.5 Cholera Vaccine (Oral Route) Customers
8 Cholera Vaccine (Oral Route) Market Dynamics
8.1 Cholera Vaccine (Oral Route) Industry Trends
8.2 Cholera Vaccine (Oral Route) Market Drivers
8.3 Cholera Vaccine (Oral Route) Market Challenges
8.4 Cholera Vaccine (Oral Route) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
